# Table 1: CPT Study Characteristics and Methodological Features

| Study ID | Test Type | N Total | ADHD n | Control n | Age (M±SD) | Setting | Study Design | Comparison Groups | Reference Standard |
|----------|-----------|----------|---------|------------|------------|---------|--------------|------------------|-------------------|
| Edebol 2013 | QbTest+ | 69 | 45 | 24 | 33±9.9 | Specialist | Diagnostic | ADHD vs Controls | Clinical diagnosis |
| Hult 2018 | QbTest | 182 | 124 | 58 | NR | Clinical | Case-control | ADHD vs ASD | DSM-5 criteria |
| Berger 2021 | MOXO-d | NR | NR | NR | College-age | Research | Simulation | ADHD vs Controls vs Simulators | Clinical diagnosis |
| Solanto 2004 | Conners CPT | NR | NR | NR | Adult | Clinical | Diagnostic | ADHD vs Clinical controls | DSM-IV criteria |

# Table 2: CPT Diagnostic Performance Metrics

| Study ID | Test Type | Sensitivity % (95% CI) | Specificity % (95% CI) | PPV | NPV | AUC (95% CI) | Cut-off Score | Parameters Used |
|----------|-----------|------------------------|------------------------|-----|-----|---------------|---------------|-----------------|
| Edebol 2013 | QbTest+ | 86 (NR) | 83 (NR) | NR | NR | NR | ≥1.5 | Q-score composite |
| Hult 2018 | QbTest | 47-67 (NR) | 72-84 (NR) | NR | NR | NR | NR | Inattention & hyperactivity |
| Berger 2021 | MOXO-d | Go: 86 (NR) NoGo: 76 (NR) | Go: 95 (NR) NoGo: 91 (NR) | NR | NR | 0.84-0.92 | NR | Multiple indices |
| Solanto 2004 | Conners CPT | NR | NR | NR | NR | NR | T>65 | Multiple indices |

Notes:
- NR = Not Reported
- CI = Confidence Interval
- PPV = Positive Predictive Value
- NPV = Negative Predictive Value
- AUC = Area Under Curve
